Brief: Cereno Scientific Granted OMPD For CS1 In Rare Disease Pulmonary Arterial Hypertension
03/09/2024 07:08
Sept 3 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* CERENO SCIENTIFIC IS GRANTED ORPHAN MEDICINAL PRODUCT
DESIGNATION IN THE EU FOR CS1 IN RARE DISEASE PULMONARY ARTERIAL
HYPERTENSION
Source text for Eikon: ID:nWkr7LnRb8
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global